Responses
ePoster Viewing: Trials-in-Progress
AS11. Ovarian cancer
TP012/#1530 Phase 2, single arm clinical trial to evaluate the safety and activity of oregovomab and niraparib in subjects with platinum sensitive recurrent ovarian cancer: flora-4
Compose a Response to This Article
Other responses
No responses have been published for this article.